The US Food and Drug Administration (FDA) is allowing Philip Morris International (PMI) to market its Iqos 3 heated tobacco device with some reduced risk claims. The decision does not override the current ban by the International Trade Commission (ITC) on Iqos sales and imports but opens the door for the company to cite the authorisation in future marketing.
This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.
Our Key Benefits
The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours